ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Gyre Therapeutics, Inc. (GYRE)

NASDAQ

$7.85

$-0.14

(-1.76%)

Gyre Therapeutics, Inc. (GYRE) Live Price Chart

Page last updated: 2026-02-11 23:49:00

Key Market Data

Market Cap	$756.22M
Open	$8.00
High	$30.40
Low	$5.88
Previous Close	$7.97
Price Change	$-0.14
Percentage Change	-1.76%
Volume	38K

Gyre Therapeutics, Inc. (GYRE) Stock Price Today

Gyre Therapeutics, Inc. (GYRE) is currently trading at $7.85 as of 2026-02-11 23:49:00, reflecting a -1.76% move ($-0.14) from the previous close.

In the short term, the stock has returned +208.06% over the past four weeks. Over the last 12 months, Gyre Therapeutics, Inc. has recorded a -32.44% price change, indicating a weak performance relative to the broader market.

Gyre Therapeutics, Inc. (GYRE) 7-Day Stock Price Changes

Over the past seven days, Gyre Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $7.64 to the latest recorded price of $7.85, reflecting an intraday change of -1.76%. Daily movements highlight shifts in trading volume (37,693), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, GYRE has delivered a +208.06% return over the past month and a -32.44% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Gyre Therapeutics, Inc. (GYRE)

You can buy and trade GYRE on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for GYRE and Execute Your Trade

Open the trading page, enter GYRE in the search bar, select the amount of GYRE you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Gyre Therapeutics, Inc. (GYRE)?

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	574
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.gyretx.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Gyre Therapeutics, Inc.?

The latest trading price for Gyre Therapeutics, Inc. (Common Stock) is $ 7.85, compared with a previous closing price of $ 7.97. That means the stock has moved -1.76% so far today. Intraday price updates and recent trading activity for GYRE can be tracked on the live chart and quote section on this page.

2.Is Gyre Therapeutics, Inc. stock going up or down?

Looking at recent performances, GYRE has returned +208.06% over the past month, 0.00% over the last six months and -32.44% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Gyre Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does GYRE currently sit relative to its 52-week high and low?

In the most recent 52-week period, Gyre Therapeutics, Inc. has traded between a low of $ 6.11 and a high of $ 13.75. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether GYRE is currently nearer the top or the bottom of its one-year trading band.

4.How is Gyre Therapeutics, Inc. classified by sector and industry?

Gyre Therapeutics, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Gyre Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing GYRE’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Gyre Therapeutics, Inc.’s performance.

5.Where is Gyre Therapeutics, Inc. listed and how large is it by market value?

Gyre Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 756.22M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Gyre Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does GYRE's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ 0.07 summarises how much profit Gyre Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Gyre Therapeutics, Inc.'s financial performance over time?

To follow Gyre Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how GYRE is performing and how the market is responding.

8.When is Gyre Therapeutics, Inc. expected to report earnings?

Gyre Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for GYRE, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Gyre Therapeutics, Inc.'s earnings reports?

Gyre Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether GYRE is meeting, beating or missing expectations.

10.How can I stay informed about Gyre Therapeutics, Inc.'s results and guidance?

You can stay up to date on Gyre Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for GYRE on this page helps you see how new information is being reflected in the stock.

11.Does Gyre Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Gyre Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor GYRE's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for GYRE?

Based on the latest earnings data, GYRE has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Gyre Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Gyre Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Gyre Therapeutics, Inc.?

Gyre Therapeutics, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is GYRE valued in terms of P/E ratio and EPS?

Gyre Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of 115.44, based on trailing-twelve-month earnings per share (EPS) of $ 0.07. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Gyre Therapeutics, Inc.'s earnings. Comparing GYRE's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Gyre Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

American Superconductor Corp.

AMSC

Charter Comm Inc Del CL A New

CHTR

Core Scientific, Inc.

CORZ

Crocs, Inc.

CROX

FACT II Acquisition Corp.

FACT

Top Gainers

Browse today's leading gainers in the US stock market

Greenlane Holdings, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

GYRE-to-USD Calculator

Amount

GYRE

USD

1 GYRE = 7.85 USD